首页> 外文期刊>Autopsy & case reports. >Severe pulmonary hypertension due to combined pulmonary fibrosis and emphysema: another cause of death among smokers
【24h】

Severe pulmonary hypertension due to combined pulmonary fibrosis and emphysema: another cause of death among smokers

机译:合并肺纤维化和肺气肿导致的严重肺动脉高压:吸烟者的另一死亡原因

获取原文
       

摘要

In 2005, the combined pulmonary fibrosis and emphysema (CPFE) was first defined as a distinct entity, which comprised centrilobular or paraseptal emphysema in the upper pulmonary lobes, and fibrosis in the lower lobes accompanied by reduced diffused capacity of the lungs for carbon monoxide (DLCO). Recently, the fibrosis associated with the connective tissue disease was also included in the diagnosis of CPFE, although the exposure to tobacco, coal, welding, agrochemical compounds, and tire manufacturing are the most frequent causative agents. This entity characteristically presents reduced DLCO with preserved lung volumes and severe pulmonary hypertension, which is not observed in emphysema and fibrosis alone. We present the case of a 63-year-old woman with a history of heavy tobacco smoking abuse, who developed progressive dyspnea, severe pulmonary hypertension, and cor pulmonale over a 2-year period. She attended the emergency facility several times complaining of worsening dyspnea that was treated as decompensate chronic obstructive pulmonary disease (COPD). The imaging examination showed paraseptal emphysema in the upper pulmonary lobes and fibrosis in the middle and lower lobes. The echo Doppler cardiogram revealed the dilation of the right cardiac chambers and pulmonary hypertension, which was confirmed by pulmonary trunk artery pressure measurement by catheterization. During this period, she was progressively restricted to the minimal activities of daily life and dependent on caregivers. She was brought to the hospital neurologically obtunded, presenting anasarca, and respiratory failure, which led her to death. The autopsy showed signs of pulmonary hypertension and findings of fibrosis and emphysema in the histological examination of the lungs. The authors highlight the importance of the recognition of this entity in case of COPD associated with severe pulmonary hypertension of unknown cause.
机译:2005年,肺纤维化和肺气肿合并症(CPFE)首次被定义为一个独特的实体,包括上肺叶的小叶或隔隔肺气肿,下肺叶的纤维化以及伴随的一氧化碳肺扩散能力降低( DLCO)。最近,尽管接触烟草,煤炭,焊接,农用化学化合物和轮胎制造是最常见的病因,但与结缔组织病相关的纤维化也被包括在CPFE的诊断中。该实体特征性地表现为DLCO降低,肺体积得以保留,严重的肺动脉高压,仅在肺气肿和纤维化中没有观察到。我们介绍了一位63岁的女性,她有严重的吸烟史,在2年的时间内发展为进行性呼吸困难,严重的肺动脉高压和肺心病。她多次去急诊室抱怨呼吸困难加重,这被认为是代偿性慢性阻塞性肺疾病(COPD)。影像学检查显示上肺叶旁有隔隔气肿,中下肺叶有纤维化。多普勒超声心动图显示右心室扩张和肺动脉高压,这通过导管插入术测得的肺干动脉压力得到证实。在此期间,她逐渐被限制在日常生活中,只能依靠照顾者。她因神经系统不适被送往医院,出现阿萨卡(anasarca)和呼吸衰竭,致死。尸检在肺组织学检查中显示出肺动脉高压的迹象以及纤维化和肺气肿的发现。作者强调指出,在COPD与原因不明的严重肺动脉高压相关的情况下,识别该实体的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号